Radiotherapy might improve survival, even in the oldest men

摘要

In a recent study, men >= 80 years who received external beam radiotherapy (EBRT) for prostate cancer lived longer than those who were observed. Greatest benefits were reported in men with moderate or aggressive disease, and those with few comorbidities. The study also emphasizes the large proportion of men who went untreated after diagnosis.